A personalized, balanced approach to antioxidant therapy is essential, alongside the development of biomarkers and standardized protocols to ensure redox homeostasis and avoid potential harm
activity is measured by a fatty acid-labeled phosphatidylserine (NBD-PS) fluorescent probe [136]
2.4 mg dose = 0.96 mL (96 units)
Diagnostic efficacy of SHOX2 gene hypermethylation for lung cancer: a meta-analysis
451 For example, in advanced soft tissue sarcoma, rechallenging with anlotinib following resistance, particularly in combination with chemotherapy, has shown promise in sustaining VEGFR pathway inhibition and disease control, especially in non-ASPS subtypes that are more chemotherapy-responsive
No large human safety trial exists